Clinical neuroscientist Joe Schacht offered an overview of the research on weight-loss drugs for alcoholism, other potential ...

GL-II-73 selectively targets GABA receptors in the hippocampus to restore brain function and repair damaged neural connections. Early studies also suggest the drug shows promise for other mental ...

Tweaking the spacing between binding domains on the ECM surrounding cancer cells can boost their killing via ultrasound ...

Oligonucleotide therapies are among the most promising biological therapeutics. They target disease at a different stage of ...

New research sheds light on how ketamine affects the brain by targeting a specific NMDA receptor subtype, GluN1-2B-2D.

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

In a new study, Cold Spring Harbor Laboratory Professor Hiro Furukawa and postdoc Hyunook Kang prove the existence of a mysterious brain receptor known as GluN1-2B-2D. They also show several ways the ...

People you wouldn’t normally associate with drug use are self-treating by microdosing with psychedelics. Doctors need to be ...

The View/ABC Whoopi Goldberg sounded off on a fake AI ad that uses her image to sell a weight-loss drug, saying, “I had nothing to do it with.” “I’m giving everybody a heads up.

Abstract: Predicting drug-target binding affinity is critical for drug discovery, as it helps identify promising drug candidates and predict their effectiveness. Recent advancements in deep learning ...

Feb 4 (Reuters) - The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' (SUPN.O), opens new tab drug-device combination to treat movement-related symptoms of Parkinson's ...

The NHS had been facing supply issues with glucagon-like peptide receptor agonists (GLP-1 RAs, or GLP-1 analogues), a range of drugs used for managing blood glucose levels in people with type 2 ...